Instil Bio, Inc.
$8.15+1.62%(+$0.13)
TickerSpark Score
51/100
80
Valuation
20
Profitability
40
Growth
84
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TIL research report →
52-Week Range7% of range
Low $5.67
Current $8.15
High $42.79
Companyinstilbio.com
Instil Bio, Inc. , a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL).
- CEO
- Bronson Crouch
- IPO
- 2021
- Employees
- 14
- HQ
- Dallas, TX, US
Price Chart
-50.43% · this period
Valuation
- Market Cap
- $55.27M
- P/E
- -1.17
- P/S
- 0.00
- P/B
- 0.50
- EV/EBITDA
- -1.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -39.76%
- ROIC
- -27.61%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-71,372,000 · 3.73%
- EPS
- $-10.70 · 6.06%
- Op Income
- $-52,907,000
- FCF YoY
- 44.26%
Performance & Tape
- 52W High
- $42.79
- 52W Low
- $5.67
- 50D MA
- $8.29
- 200D MA
- $13.70
- Beta
- 1.95
- Avg Volume
- 28.45K
Get TickerSpark's AI analysis on TIL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 10, 25 | Laumas Sandeep | other | 13,000 |
| Sep 10, 25 | Laumas Sandeep | other | 13,000 |
| Sep 10, 25 | Laumas Sandeep | other | 17,000 |
| Sep 10, 25 | Laumas Sandeep | other | 17,000 |
| Sep 10, 25 | Laumas Sandeep | sell | 17,539 |
| Sep 10, 25 | Laumas Sandeep | sell | 12,461 |
| May 28, 25 | Binder Gwendolyn | other | 6,500 |
| May 28, 25 | Gibson Neil W | other | 6,500 |
| May 28, 25 | Matcham George | other | 6,500 |
| May 28, 25 | McGaughy R Kent Jr | other | 6,500 |
Our TIL Coverage
We haven't published any research on TIL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TIL Report →Similar Companies
ZNTL+5.23%
Zentalis Pharmaceuticals, Inc.
$3.73
SRZN+3.55%
Surrozen, Inc.
$26.48
PLRX+5.65%
Pliant Therapeutics, Inc.
$1.22
ONCY+7.46%
Oncolytics Biotech Inc.
$0.83
ATOS+2.32%
Atossa Therapeutics, Inc.
$4.86
WHWK+2.95%
Whitehawk Therapeutics Inc
$4.19
MGNX-0.55%
MacroGenics, Inc.
$4.50
TVGN+2.43%
Tevogen Bio Holdings Inc.
$10.11